Puheng Pharma

Puheng Biomedicine is an innovative biotechnology company specializing in the development of advanced in vitro 3D physiological and pathological models for drug discovery and assessment. The company's core technology, NAC-Organ, utilizes synthetic biology and DNA origami-based nucleic acid nanostructures to enable the standardized, high-throughput assembly of complex humanized tissue models, including organoids and organ-on-a-chip systems. Puheng provides specialized testing platforms for hepatotoxicity, chronic liver diseases such as NASH/MASH, and solid tumor microenvironments, serving pharmaceutical companies and research institutions. By integrating artificial intelligence with 3D cell culture, the company aims to significantly shorten drug development cycles and improve the predictive accuracy of preclinical safety and efficacy evaluations.